Advertisement

Applied Microbiology and Biotechnology

, Volume 79, Issue 5, pp 829–841 | Cite as

Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and antioxidative effect

  • Chun-Lin Lee
  • Jyh-Jye Wang
  • Tzu-Ming PanEmail author
Applied Microbial and Cell Physiology

Abstract

Amyloid β-peptide (Aβ), a risk of Alzheimer's disease (AD), causes cell death by inflammation and oxidative stress. Red mold rice (RMR) fermented by Monascus species is regarded as cholesterol-lowering functional food in virtue of the metabolite monacolin K identified as lovastatin. In addition, RMR is also demonstrated to express antioxidation because of multiple antioxidants. Therefore, this study focuses on the synergism of RMR against Aβ neurotoxicity and compares the effect between lovastatin and RMR including monacolin K and other functional metabolites. In this study, RE 568, an ethanol extract of RMR produced by strain Monascus purpureus NTU 568, is used to protect PC12 cell against Aβ40 neurotoxicity. All tests contain the treatments with lovastatin or RE 568 including equal monacolin K levels in order to compare the effect and investigate whether other metabolites of RE 568 provide potent assistance against Aβ40 neurotoxicity. In the results, monacolin K represses Aβ40 neurotoxicity via repressing small G-protein-mediated inflammation, and other metabolites of RE 568 also exhibit potent antioxidative ability against Aβ-induced oxidative stress. Importantly, stronger effects on repressing the Aβ40-induced cell death, inflammation, and oxidative stress are performed by RE 568 than that by the equal levels of lovastatin, which results from a potent synergism made up of monacolin K, antioxidants, and anti-inflammatory agents. The present study is the first report to demonstrate the potent synergistic protection of RMR against Aβ40 neurotoxicity, which would cause RMR to be developed as potential and novel functional food for the prophylaxis of AD pathogenesis.

Keywords

Alzheimer's disease Amyloid Monascus Monacolin K Anti-inflammatory Antioxidative 

Notes

Acknowledgments

This study was supported by a grant from the National Science Council, R.O.C. (NSC95-2313-B-002-019).

References

  1. Akihisa T, Tokuda H, Yasukawa K, Ukiya M, Kiyota A, Sakamoto N, Suzuki T, Tanabe N, Nishino H (2005) Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects. J Agric Food Chem 53:562–565CrossRefGoogle Scholar
  2. Aniya Y, Yokomakura T, Yonamine M, Shimada K, Nagamine T, Shimabukuro M, Gibo H (1999) Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats. Gen Pharmacol 32:225–231CrossRefGoogle Scholar
  3. Aniya Y, Ohtani II, Higa T, Miyagi C, Gibo H, Shimabukuro M, Nakanishi H, Taira J (2000) Dimerumic acid as an antioxidant of the mold, Monascus anka. Free Radic Biol Med 28:999–1004CrossRefGoogle Scholar
  4. Beers RFJ, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–140Google Scholar
  5. Buxbaum JD, Thinakaran G, Koliatsos V, O, Callahan J, Slunt HH, Price DL, Sisodia SS (1998) Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci 18:9629–9637Google Scholar
  6. Cahlin C, Gelin J, Andersson M, Lonnroth C, Lundholm K (2005) The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors. Int J Oncol 27:913–923Google Scholar
  7. Cordle A, Landreth G (2005) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. J Neurosci 25:299–307CrossRefGoogle Scholar
  8. Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth G (2005) Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 280:34202–34209CrossRefGoogle Scholar
  9. Davignon J, Mabile L (2001) Mechanisms of action of statins and their pleiotropic effects. Ann Endocrinol (Paris) 62:101–112Google Scholar
  10. Endo A (1979) Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo) 32:852–854Google Scholar
  11. Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T (2006) Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 399:91–95CrossRefGoogle Scholar
  12. Gao X, Tang XC (2006) Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J Neurosci Res 83:1048–1057CrossRefGoogle Scholar
  13. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138CrossRefGoogle Scholar
  14. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL (1999) Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 69:231–236Google Scholar
  15. Heo HJ, Kim DO, Choi SJ, Shin DH, Lee CY (2004) Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J Agric Food Chem 52:4128–4132CrossRefGoogle Scholar
  16. Hoglund K, Wiklund O, Vanderstichele H, Eikenberg O, Vanmechelen E, Blennow K (2004) Plasma levels of beta-amyloid(1–40), beta-amyloid(1–42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins. Arch Neurol 61:333–337CrossRefGoogle Scholar
  17. Iskra B, Zivko M, Kes P (2005) Rhabdomyolysis as a side effect of simvastatin treatment. Acta Med Croatica 59:325–328Google Scholar
  18. Iuvone T, De Filippis D, Esposito G, D, Amico A, Izzo AA (2006) The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther 317:1143–1149CrossRefGoogle Scholar
  19. Jang JH, Aruoma OI, Jen LS, Chung HY, Surh YJ (2004) Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death. Free Radic Biol Med 36:288–299CrossRefGoogle Scholar
  20. Juzlova P, Martinkova L, Kren V (1996a) Secondary metabolites of the fungus Monascus: a review. J Ind Microbiol 16:163–170CrossRefGoogle Scholar
  21. Juzlova P, Rezanka T, Martinkova L, Kren V (1996b) Long-chain fatty acids from Monascus purpureus. Phytochemistry 43:151–153CrossRefGoogle Scholar
  22. Lee SY, Lee JW, Lee H, Yoo HS, Yun YP, Oh KW, Ha TY, Hong JT (2005) Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res Mol Brain Res 140:45–54CrossRefGoogle Scholar
  23. Lee CL, Tsai TY, Wang JJ, Pan TM (2006a) In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl Microbiol Biotechnol 70:533–540CrossRefGoogle Scholar
  24. Lee CL, Wang JJ, Kuo SL, Pan TM (2006b) Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent-monacolin K and anti-inflammation agent-monascin. Appl Microbiol Biotechnol 72:1254–1262CrossRefGoogle Scholar
  25. Lee CL, Wang JJ, Pan TM (2006c) Synchronous analysis method for detection of citrinin and the lactone and acid forms of monacolin K in red mold rice. J AOAC Int 89:669–677Google Scholar
  26. Lee HG, Zhu X, Nunomura A, Perry G, Smith MA (2006d) Amyloid beta: the alternate hypothesis. Curr Alzheimer Res 3:75–80CrossRefGoogle Scholar
  27. Lee CL, Hung HK, Wang JJ, Pan TM (2007) Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters. J Agric Food Chem 55:7162–7169CrossRefGoogle Scholar
  28. Li Z, Seeram NP, Lee R, Thames G, Minutti C, Wang HJ, Heber D (2005) Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers. J Altern Complement Med 11:1031–1038CrossRefGoogle Scholar
  29. Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89–118CrossRefGoogle Scholar
  30. Lingnert H, Vallentin K, Eriksson CE (1979) Measurement of antioxidative in model system. J Food Process Preserv 3:87–103CrossRefGoogle Scholar
  31. Oyaizu M (1986) Antioxidative activity of browning products of glucosamine fractionated by organic solvent and thin-layer chromatography. Nippon Shokuhin Kogyo Gakkaishi 35:771–775Google Scholar
  32. Pollack SJ, Sadler II, Hawtin SR, Tailor VJ, Shearman MS (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett 184:113–116CrossRefGoogle Scholar
  33. Raja SG, Dreyfus GD (2004) Statins: much more than just a lipid-lowering therapy. Indian Heart J 56:204–209Google Scholar
  34. Rhyu MR, Kim DK, Kim HY, Kim BK (2000) Nitric oxide-mediated endothelium-dependent relaxation of rat thoracic aorta induced by aqueous extract of red rice fermented with Monascus ruber. J Ethnopharmacol 70:29–34CrossRefGoogle Scholar
  35. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 59:223–227CrossRefGoogle Scholar
  36. Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 24:167–176CrossRefGoogle Scholar
  37. Scott HD, Laake K (2001) Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev 2001(3):CD003160Google Scholar
  38. Setnikar I, Senin P, Rovati LC (2005) Antiatherosclerotic efficacy of policosanol, red yeast rice extract and astaxanthin in the rabbit. Arzneimittelforschung 55:312–317Google Scholar
  39. Su YC, Wang JJ, Lin TT, Pan TM (2003) Production of the secondary metabolites gamma-aminobutyric acid and monacolin K by Monascus. J Ind Microbiol Biotechnol 30:41–46Google Scholar
  40. Townsend KP, Pratico D (2005) Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. Faseb J 19:1592–1601CrossRefGoogle Scholar
  41. Wei W, Li C, Wang Y, Su H, Zhu J, Kritchevsky D (2003) Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. J Nutr Biochem 14:314–318CrossRefGoogle Scholar
  42. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439–1443CrossRefGoogle Scholar
  43. Wu LC, Chen YC, Ho JA, Yang CS (2003) Inhibitory effect of red koji extracts on mushroom tyrosinase. J Agric Food Chem 51:4240–4246CrossRefGoogle Scholar
  44. Xiao XQ, Wang R, Tang XC (2000) Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J Neurosci Res 61:564–569CrossRefGoogle Scholar
  45. Yallampalli S, Micci MA, Taglialatela G (1998) Ascorbic acid prevents beta-amyloid-induced intracellular calcium increase and cell death in PC12 cells. Neurosci Lett 251:105–108CrossRefGoogle Scholar
  46. Zhao B (2005) Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 31:283–293CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.R&D DivisionSunway Biotechnology Company LimitedTaipeiTaiwan
  2. 2.Department of BiotechnologyTajen UniversityPing TungTaiwan
  3. 3.Institute of Microbiology and BiochemistryNational Taiwan UniversityTaipeiTaiwan

Personalised recommendations